All Articles

Asahi Kasei and Teijin merge key units. Is this a defensive move or a bold new strategy for global competitiveness in the high-tech materials market?

In a bold move, NVA appoints a Johnson & Johnson veteran to lead its specialty vet network. What does this mean for the future of your pet's health?

Formerly a cannabis firm, Mixie Technologies is pivoting hard into AI with a key acquisition. Is this a savvy play on a $250B market or a risky reinvention?

Facing new EU regulations, automakers are launching a collaborative program to help their European suppliers adopt renewable energy and cut emissions.

A new frontier in luxury is emerging: freedom from chronic disease. Mapi Pharma's push into long-acting injectables signals a high-value market shift.

A new treatment center's launch in New Jersey reveals a key trend: specialized entrepreneurs are challenging large providers in behavioral health.

State Street consolidates its massive SPDR ETF suite, ending a key partnership to enhance investor tools and tighten its grip in the asset management race.

Struggling with financial headwinds, Rail Vision is making a bold leap, acquiring a quantum computing firm to revolutionize railway safety. Is it genius or desperation?

Amid financial headwinds, Planet Green (PLAG) launches a premium tea series, blending ancient tradition with modern taste to tap China's booming market.

A critical shortage of cyber experts meets a surge in AI-powered attacks in Japan. A new alliance is deploying autonomous AI agents to protect the nation's digital wealth.

CrowdStrike and AWS are lowering security barriers, making advanced protection on the cloud more accessible and efficient for healthcare organizations.

A new report reveals community cancer centers are hubs of innovation. Discover how this trend is making healthcare access a top driver for luxury home sales.

Allspring's latest fund notice reveals a high yield funded by returning investor capital. We unpack the 'yield trap' and what it means for your portfolio.

Global Ship Lease's latest acquisition isn't just a purchase; it's a strategic masterstroke in capital recycling and market timing. Here's why.

Bolt's new network-based identity system uses device verification to fight rampant synthetic fraud, promising safer e-commerce for merchants and shoppers.

New federal rules make banking cheaper and more accessible for millions, especially newcomers, Indigenous peoples, and those with disabilities. Here's how.

A new DoD-funded study will test an AI-powered oxygen system in ambulances, promising to save lives on the battlefield and in civilian emergencies.

Biodexa Pharmaceuticals expands its pivotal Phase 3 trial for eRapa into Europe, a key step in tapping a $7B market for a rare cancer-causing disease.

Akamai's acquisition of WebAssembly leader Fermyon signals a major shift, promising faster, cheaper, and more secure AI for logistics and manufacturing.

With a key Wyoming project near production, U.S. Gold Corp. heads to a top London conference, a strategic play on domestic resources in a volatile world.